Author:
Haghpanah Sezaneh,Zekavat Omid Reza,Safaei Sanaz,Ashraf Mohammad Ali,Parand Shirin,Ashraf Hossein
Abstract
Abstract
Background
Structural ophthalmologic findings have been reported in patients with β-thalassemia due to chronic anemia, iron overload, and iron chelation therapy toxicity in few previous studies. We aimed to investigate structural ocular findings and their relationship with hematological parameters in patients with transfusion-dependent β-thalassemia (TDT).
Methods
In this cross-sectional study, from January 2018 to January 2019, 39 patients with TDT over the age of 18 participated. Multicolor fundus imaging, optical coherence tomography (OCT), and blue light fundus autofluorescence imaging were performed for all patients and 27 age- and sex-matched controls.
Results
The mean age of patients was 28.6 ± 6.2 years. The central macular thickness and macular thicknesses in all quadrants were significantly thinner in patients than controls (P<0.05). None of the retinal nerve fiber layer (RNFL) measurements were significantly different between TDT patients and controls. There was a significantly negative correlation between hemoglobin with central macula thickness (r=-0.439, P=0.005). All measurements of macular subfield thickness were insignificantly thinner in patients with diabetes mellitus (DM) compared to the non-DM subgroup.
Conclusions
Macular thickness was significantly thinner in central macula and entire quadrants in TDT patients compared to healthy individuals; however, all RNFL measurement thicknesses were comparable between the two groups. Close monitoring of TDT patients by periodic ophthalmologic examinations with more focus on diabetic patients, patients with severe anemia and iron overload should be warranted.
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference35 articles.
1. Taneja R, Malik P, Sharma M, Agarwal MC. Multiple transfused thalassemia major: ocular manifestations in a hospital-based population. Indian J Ophthalmol. 2010;58(2):125.
2. Dell'Edera D, Epifania AA, Malvasi A, Pacella E, Tinelli A, Capalbo A, et al. Incidence of β-thalassemia carrier on 1495 couples in preconceptional period. J Matern Fetal Neonatal Med. 2013;26(5):445–8.
3. Taher A, Bashshur Z, Shamseddeen WA, REE A, Aoun E, Koussa S, et al. Ocular findings among thalassemia patients. Am J Ophthalmol. 2006;142(4):704–5.
4. Abdel-Malak DS, Dabbous OA, Saif MY, Saif ATS. Ocular manifestations in children with β thalassemia major and visual toxicity of iron chelating agents. J Am Sci. 2012;8(7):633–8.
5. Liaska A, Petrou P, Georgakopoulos CD, Diamanti R, Papaconstantinou D, Kanakis MG, et al. beta-Thalassemia and ocular implications: a systematic review. BMC Ophthalmol. 2016;16:102.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献